Volume 120; Issue supp-S1

Main
Gynecologic Oncology
Volume 120; Issue supp-S1

Gynecologic Oncology

Volume 120; Issue supp-S1

1

A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally advanced squamous cell carcinoma of the vulva: A Gynecologic Oncology Group study

D. Moore, S. Ali, M. Barnes, W. Koh, H. Michael, C. McCourt, H. Homesley, J. Walker

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 105 KB

english, 2011

2

From guidelines to the front line: Only a minority of the Medicare population with advanced epithelial ovarian cancer receive optimal therapy

M. Thrall, D. Flum, R. Symons, N. Weiss, H. Gray, B. Goff

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 269 KB

english, 2011

3

RETRACTED: A 3’ UTR KRAS variant as a biomarker of poor outcome and chemotherapy resistance in ovarian cancer

E. Ratner, F. Keane, H. Yu, D. Zelterman, T. Rutherford, A. Santin, P. Schwartz, F. Slack, D. Levine, J. Weidhaas

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 206 KB

english, 2011

4

Effectiveness of a program to prevent cervical cancer among HIV-infected women in Zambia

G. Parham, M. Mwanahamuntu, V. Sahasrabuhhde

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 216 KB

english, 2011

5

Incidence of nodal metastasis in endometrioid endometrial cancer risk groups: A Gynecologic Oncology Group multicenter review

M. Milam, J. Java, J. Walker, L. Parker, D. Metzinger, R. Coleman

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 55 KB

english, 2011

6

MicroRNA as a novel predictor of response to bevacizumab in recurrent serous ovarian cancer: An analysis of The Cancer Genome Atlas

J. Chan, T. Kiet, A. Sherman, K. Fuh, S. Ueda, R. Brooks, D. Kapp, L. Chen, B. Monk

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 73 KB

english, 2011

7

Prospective investigation of risk factors for gastrointestinal adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer: A Gynecologic Oncology Group study

R. Burger, M. Brady, M. Bookman, B. Monk, J. Walker, H. Homesley, J. Fowler, B. Greer, M. Boente, S. Liang

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 55 KB

english, 2011

8

First in human trial of the poly(ADP)-ribose polymerase inhibitor MK-4827 in patients with advanced cancer with antitumor activity in BRCA-deficient and sporadic ovarian cancers

R. Wenham, G. Wilding, R. Baird, L. Sun, C. Toniatti, M. Stroh, C. Carpenter, J. de-Bono, S. Sandhu, W. Schelman

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 71 KB

english, 2011

9

A unique microRNA locus at 19q13.41 sensitizes epithelial ovarian cancers to chemotherapy

C. Mach, J. Kim, C. Creighton, P. Gunaratne, M. Anderson

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

10

Ovarian cancer: Predictors of primary care physicians' referral to gynecologic oncologists

B. Goff, H. Andrilla, L. Baldwin, D. Lishner, B. Matthews, J. Miller, K. Trivers

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

11

Uterine serous papillary carcinomas overexpress human trophoblast cell surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody

A. Santin, S. Bellone, J. Varughese, E. Cocco, E. Ratner, D. Silasi, T. Rutherford, P. Schwartz, M. Azodi, S. Pecorelli

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 70 KB

english, 2011

12

Common single-nucleotide polymorphisms in the BNC2, HOXD1 and MERIT40 regions contribute significantly to racial differences in ovarian cancer incidence

A. Berchuck, M. Pike, J. Schildkraut, C. Pearce

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

13

XPC single-nucleotide polymorphisms correlate with prolonged progression-free survival in advanced ovarian cancer

N. Fleming, H. Agadjanian, C. Miller, S. Orsulic, B. Karlan, C. Walsh

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 234 KB

english, 2011

14

Genomewide methylation analyses reveal a prominent role of HINF1 network genes, via hypomethylation, in ovarian clear cell carcinoma

K. Yamaguchi, T. Baba, N. Matsumura, M. Mandai, I. Konishi, A. Berchuck, S. Murphy

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 216 KB

english, 2011

15

KLF6-SV1 is a novel uterine leiomyosarcoma gene: From transgenic mouse model to human disease

A. DiFeo, R. Sennet, F. Huang, D. Levine, T. Kalir, M. van de Rijn, P. Dottino, J. Martignetti

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 222 KB

english, 2011

16

Single-incision laparoscopic staging surgery for endometrial cancer

D. Boruta, C. McCann, W. Growdon

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

17

Single-port paraaortic lymph node dissection

M. Liotta, P. Escobar

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

18

Robotic nerve-sparing radical hysterectomy type C1

J. Magrina, W. Pawlina, R. Kho, P. Magtibay

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

19

Urinary reconstruction after pelvic exenteration: Modified Indiana pouch

F. Khoury Collado, Y. Sonoda, B. Bochner

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

20

Intrathoracic cytoreductive surgery by video-assisted thoracic surgery in advanced ovarian carcinoma

J. Diaz, B. Park, Y. Sonoda, D. Chi

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

21

Prospective phase II trial of adjuvant pelvic radiation “sandwiched” between paclitaxel and carboplatin combination chemotherapy in women with uterine papillary serous carcinoma

M. Einstein, M. Frimer, R. Phaeton, L. Reimers, K. Mehta, S. Mutyala, D. Kuo, G. Goldberg

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 110 KB

english, 2011

22

Randomized controlled trial of laparoscopic approach to carcinoma of the endometrium (LACE): Prevalence and risk factors for surgical complications

S. Kondalsamy-Chennakesavan, M. Janda, V. Gebski, J. Nicklin, T. Jobling, R. Land, T. Manolitsas, A. McCartney, L. Perrin, A. Obermair

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 90 KB

english, 2011

23

Postmenopausal endometrial cancer: Reevaluating the role of the endometrial echo complex

U. Chandavarkar, J. Kuperman, L. Muderspach, C. Morrow, A. Yessaian, H. Pham, Y. Lin, L. Roman

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 188 KB

english, 2011

24

Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer

D. Teoh, E. Myers, A. Berchuck, A. Alvarez-Secord, P. Lee, W. Lowery, G. Sfakianos, L. Havrilesky

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 132 KB

english, 2011

25

Evaluation of the outcome benefit conferred by intensive surveillance strategies in women with early-stage endometrial cancer

J. Kesterson, G. Kiran, K. Ozerkan, M. Kanis, A. Groman, S. Lele

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 149 KB

english, 2011

26

Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer

J. Rauh-Hain, W. Growdon, N. Rodriguez, A. Goodman, D. Boruta, N. Horowitz, M. Del Carmen, J. Schorge

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 102 KB

english, 2011

27

Treatment of chemotherapy-induced anemia in patients with ovarian cancer: Does the use of erythropoiesis-stimulating agents worsen survival?

R. Rocconi, B. Long, P. Sullivan, M. Blaize, J. Brown, J. Arbuckle, K. Bevis, J. Estes, E. Reed, M. Finan

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 86 KB

english, 2011

28

An economic analysis of intravenous carboplatin plus dose-dense weekly paclitaxel versus intravenous carboplatin plus every three-weeks paclitaxel in the upfront treatment of ovarian cancer

H. Dalton, X. Yu, L. Hu, B. Monk, I. Benjamin, J. Chan

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 86 KB

english, 2011

29

Should stage IIIC ovarian cancer be further stratified by intraperitoneal versus retroperitoneal-only disease? A Gynecologic Oncology Group study

B. Rungruang, A. Miller, S. Richard, C. Hamilton, N. Rodriguez, M. Bookman, G. Maxwell, T. Krivak, N. Horowitz

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 172 KB

english, 2011

30

Efficacy of influenza vaccination in women with ovarian cancer

C. Chu, J. Boyer, A. Jawad, N. Prak, K. Sullivan

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 123 KB

english, 2011

31

Does the bedside assistant matter in robotic surgery: An analysis of patient outcomes in gynecologic oncology

M. Martino, R. Miller, J. Shubella, S. Williams, M. Thomas, R. Boulay

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

32

Comparison of single-port laparoscopy versus standard laparoscopy versus robotic surgery in patients with endometrial cancer: A multi-institutional study

P. Escobar, M. Frumovitz, P. Soliman, H. Frasure, D. Starks, A. Nickles Fader, P. Ramirez

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

33

Adenocarcinoma of the cervix: Is radical vaginal trachelectomy safe?

L. Helpman, A. Covens, D. Grisaru

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 91 KB

english, 2011

34

The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma

J. Park, S. Park, J. Kim, Y. Kim, Y. Kim, J. Nam

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 76 KB

english, 2011

35

Efficacy of the ASO4-adjuvanted HPV-16/18 vaccine in reduction of abnormal cytology, colposcopy referrals and cervical excision therapies: PATRICIA end-of-study results

C. Wheeler, J. Paavonen, P. Naud, J. Salmeron, S. Chow, D. Apter, H. Kitchener, X. Castellsagué, J. Teixeira

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 93 KB

english, 2011

36

The utility of preoperative CA-125 in the management of apparent early-stage endometrial cancer

J. Nicklin, M. Janda, V. Gebski, T. Jobling, R. Land, T. Manolitsas, A. McCartney, M. Nascimento, L. Perrin, A. Obermair

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

37

BRCAness profile of ovarian cancer predicts disease recurrence

T. Pejovic, H. Li, S. Syriac, W. Zhang, P. Mhawech-Fauceglia

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

38

Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes

F. Khoury Collado, M. Murray, Y. Sonoda, D. Levine, M. Leitao, D. Chi, R. Barakat, N. Abu-Rustum

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 70 KB

english, 2011

39

The role of lymphadenectomy in endometrial cancer: Was the ASTEC trial doomed by design and are we destined to repeat that mistake?

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

40

Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or nonsquamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

A. Santin, G. Patricia, M. Sill, D. McMeekin, M. Leitao, J. Brown, G. Sutton, L. Van Le, C. Boardman

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 55 KB

english, 2011

41

Cervical cancer rates in clinical practice with co-testing, interval extension and current evaluation of women with pap-negative, human papillomavirus-positive screening tests

H. Dinkelspiel, N. Poitras, B. Fetterman, W. Kinney, T. Cox, T. Lorey, P. Castle

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

42

Establishing an optimal sentinel lymph node mapping algorithm for the treatment of early cervical cancer

B. Cormier, J. Diaz, K. Shih, R. Sampson, Y. Sonoda, K. Park, D. Chi, R. Barakat, K. Alektiar, N. Abu-Rustum

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

43

Comparison of radical hysterectomy with chemoradiation therapy for stage IB2 and IIA2 cervical cancer

J. Park, J. Kim, S. Park, J. Nam

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 159 KB

english, 2011

44

Development of a preclinical serous ovarian cancer mouse model

V. Bae-Jump, C. Yin, X. Zong, T. Van Dyke

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 144 KB

english, 2011

45

Impact of episodic transparent quality assessment on the staging of endometrial cancer

K. Podratz, S. Dowdy, J. Bakkum-Gamez, A. Weaver, M. McGree, W. Cliby, B. Gostout, T. Wilson, G. Keeney, A. Mariani

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 164 KB

english, 2011

46

Defining the limits of radical cytoreductive surgery for ovarian cancer

J. Wright, S. Lewin, I. Deutsch, X. Sun, W. Burke, T. Herzog

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

47

Loss of ARID1A is a frequent event in clear cell and endometrioid ovarian cancers

W. Lowery, J. Schildkraut, L. Akushevich, R. Bentley, D. Huntsman, J. Marks, A. Berchuck

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

48

Trends in utilization and cost of minimally invasive robotic surgery for endometrial cancer: A statewide analysis of 2296 patients

X. Yu, R. Brooks, D. Lum, T. Kiet, K. Fuh, R. Brooks, J. Orr, D. Kapp, J. Chan

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 69 KB

english, 2011

49

BRCA1-deficient tumors demonstrate enhanced cytotoxicity and T-cell recruitment following doxil treatment

G. Mantia-Smaldone, E. Marsh, R. Loomis, S. Orsulic, S. Rubin, G. Coukos, S. Adams

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

50

A history of breast carcinoma predicts worse survival in BRCA1 and BRCA2 mutation carriers with ovarian carcinoma

B. Norquist, R. Garcia, K. Agnew, J. Gross, R. Swensen, B. Goff, H. Gray, B. Karlan, E. Swisher

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 155 KB

english, 2011

51

Genetic variants in the mammalian target of rapamycin (mTOR) signaling pathway as predictors of clinical response and survival in women with ovarian cancer

L. Meyer, D. Liang, J. Lin, Y. Ye, M. Huang, X. Pu, K. Lu, X. Wu

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 139 KB

english, 2011

52

A novel combination of a MEK inhibitor and fulvestrant shows synergistic antitumor activity in estrogen receptor-positive ovarian carcinoma

J. Hou, A. Rodriguez-Gabin, S. Horwitz, G. Goldberg, H. McDaid

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 230 KB

english, 2011

53

BAD apoptosis pathway expression and survival from cancer

J. Lancaster, D. Chen, D. Marchion, Y. Xiong, A. Berchuck, P. Judson, J. Gonzalez Bosquet, R. Wenham, S. Apte, W. Fulp

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 125 KB

english, 2011

54

Examination of matched primary and recurrent ovarian cancer specimens supports the cancer stem cell hypothesis

K. Bevis, A. Steg, A. Katre, B. Erickson, T. Backes, K. Zhang, P. Frederick, M. Conner, C. Landen

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 141 KB

english, 2011

55

Hypoxia-mediated activation of signal transducer and activator of transcription 3 (STAT3) in ovarian cancer: A novel therapeutic strategy using HO-3867, a STAT3 inhibitor

G. McCann, K. Selvendiran, K. Hideg, D. Cohn, P. Kuppusamy

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

56

Modeling of early events in serous carcinogenesis: Molecular prerequisites for transformation of fallopian tube epithelial cells

A. Jazaeri, J. Bryant, H. Park, J. Ferriss, H. Li, A. Dutta

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 65 KB

english, 2011

57

Molecular profiling of advanced pelvic serous carcinoma associated with serous tubal intraepithelial carcinoma

D. Levine, F. Bogomolniy, F. Dao, N. Olvera, G. Han, R. Soslow

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

58

Prospective identification of epigenetic signatures that predict clinical outcomes in high-risk human papillomavirus-positive early cervical intraepithelial neoplasia

M. Einstein, T. Belbin, L. Adrien, G. Goldberg, H. Strickler, R. Burk, N. Schlecht

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

59

The ubiquitin ligase EDD mediates platinum resistance and is a target for therapy in epithelial ovarian cancer

A. Ziebarth, H. Zheng, A. Bradley, W. Sakati, S. Eier, G. Lopez-Berestein, A. Sood, S. Eblen, C. Landen

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 66 KB

english, 2011

60

Does a uterine manipulator affect cervical cancer pathology or identification of lymphovascular space involvement?

J. Rakowski, M. Radi, S. Ahmad, L. Brudie, J. James, R. Holloway

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

61

Pap-negative, human papillomavirus-positive screening results: Compliance with follow-up and results of follow-up

H. Dinkelspiel, N. Poitras, B. Fetterman, W. Kinney, T. Cox, T. Lorey, P. Castle

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 66 KB

english, 2011

62

Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer

C. Kim, N. Abu-Rustum, D. Chi, G. Gardner, M. Leitao, J. Carter, R. Barakat, Y. Sonoda

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

63

Residing in a county with higher percentage of language isolation is associated with increased incidence of invasive squamous cell carcinoma of the cervix among Hispanic women

K. Ward, A. Roncancio, S. Plaxe

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

64

Stage IB2 cervical cancer: A decision analysis comparing quality-adjusted survival associated with chemoradiation versus radical surgery with tailored adjuvant chemoradiation

M. Einstein, J. Hollenberg, E. Hartenbach, R. Chappell, D. Kushner, A. Evans, J. Connor

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 131 KB

english, 2011

65

The vaginal radical trachelectomy: An update of a series of 125 cases and 106 pregnancies

M. Plante, J. Grégoire, M. Renaud, M. Roy

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 113 KB

english, 2011

66

An economic analysis of bevacizumab in recurrent treatment of ovarian cancer

J. Chan, B. Monk, K. Fuh, R. Urban, L. Hu, A. Caughey, X. Yu

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 127 KB

english, 2011

67

Intraperitoneal chemotherapy for recurrent ovarian cancer appears efficacious with high completion rates and low complications

M. Skaznik-Wikiel, J. Lesnock, W. McBee, S. Taylor, S. Beriwal, A. Smith, K. Zorn, S. Richard, T. Krivak, R. Edwards

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

68

Clinical practice guidelines decrease unnecessary Pap tests in survivors of gynecologic malignancies

L. Meyer, K. Schmeler, J. Wallbillich, D. Urbauer, P. Soliman, M. Frumovitz, C. Burke, D. Bodurka, C. Levenback

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 149 KB

english, 2011

69

A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer

E. Eisenhauer, V. Zanagnolo, D. Cohn, R. Salani, D. O'Malley, G. Sutton, B. Cobb, M. Vaughan, J. Fowler, L. Copeland

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 134 KB

english, 2011

70

A phase I clinical trial of a novel infectivity-enhanced suicide gene adenovirus with gene transfer imaging capacity in patients with recurrent gynecologic cancer

K. Kim, M. Wang, M. Barnes, J. O'Malley, Z. You, M. Preuss, G. Siegal, K. Zinn, D. Curiel, R. Alvarez

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 139 KB

english, 2011

71

A phase I study of a novel lipopolymer-based interleukin-12 gene therapeutic in combination with chemotherapy for the treatment of platinum-sensitive recurrent ovarian cancer

R. Alvarez, K. Anwar, M. Barnes, J. Fewell

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 55 KB

english, 2011

72

AMG 386 combined with either pegylated liposomal doxorubicin or topotecan in patients with advanced ovarian cancer: Results from a phase Ib study

R. Wenham, R. Schilder, C. Pippitt, S. Wong, S. Ananda, S. Scudder, R. Melara, N. Nanayakkara, H. Adewoye, I. Vergote

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 58 KB

english, 2011

73

A phase II evaluation of carboplatin/paclitaxel/bevacizumab in the treatment of advanced-stage endometrial carcinoma: Report of toxicity

D. OMalley, P. Gary, R. Salani, E. Eisenhauer, J. Fowler, L. Copeland, D. Cohn

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

74

Do uterine risk factors or lymph node metastases drive overall recurrence risk in patients with endometrial cancer?

E. Bishop, E. Nugent, C. Mathews, K. Moxley, M. Tenney, R. Mannel, J. Walker, L. Landrum, K. Moore, D. McMeekin

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

75

Outcomes in patients with surgically staged, high-intermediate risk endometrial cancer in the absence of adjuvant therapy

K. Moxley, C. Mathews, D. McMeekin, L. Landrum, J. Walker, R. Mannel, K. Moore

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 66 KB

english, 2011

76

Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma

P. Convery, L. Cantrell, S. Modesitt, A. Alvarez-Secord, L. Havrilesky

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

77

Identifying Lynch syndrome in women with endometrial cancer

L. Chen, J. Holstein, A. Blanco, J. Chan, C. Powell, J. Rabban, J. Grenert, P. Conrad

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

78

Ten-year relative survival for epithelial ovarian cancer

L. Baldwin, R. Ware, B. Huang, T. Tucker, S. Goodrich, I. Podzielinski, C. DeSimone, F. Ueland, J. van Nagell, L. Seamon

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 65 KB

english, 2011

79

Availability of gynecologic oncologists for ovarian cancer care

D. Cooney, B. Spruell, S. Rim, S. Foster, S. Lawvere, L. Richardson, C. Thomas, S. Stewart

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

80

Biologic roles of tumor and endothelial delta-like ligand 4 in ovarian cancer

W. Hu, C. Lu, R. Stone, J. Bottsford-Miller, A. Nick, M. Shahzad, K. Matsuo, R. Coleman, A. Sood

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 64 KB

english, 2011

81

Impact of beta blockers on epithelial ovarian cancer survival

E. Diaz, B. Karlan, I. Cass, C. Walsh, A. Li

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

82

Long-term survival of patients with epithelial ovarian cancer detected by sonographic screening

R. Miller, C. DeSimone, F. Ueland, L. Seamon, I. Podzielinski, S. Goodrich, J. Elder, E. Pavlik, J. van Nagell

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

83

MicroRNA 101 inhibits ovarian cancer xenografts by relieving the chromatin-mediated transcriptional repression of p21waf1/cip1

A. Semaan, A. Qazi, S. Seward, R. Ali-Fehmi, R. Morris, A. Munkarah, V. Dhulipala, C. Steffes, D. Weaver, B. Ramesh

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 64 KB

english, 2011

84

Pressure to respond: Hypertension predicts clinical benefit from bevacizumab in recurrent ovarian cancer

A. Nick, R. Stone, P. Soliman, A. Sood, D. Gershenson, R. Coleman, P. Ramirez

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

85

Prognostic impact of lymphadenectomy in clinically early-stage ovarian malignant germ cell tumor

H. Mahdi, R. Hanna, S. Seward, R. Swensen, H. Tamimi, R. Morris, A. Munkarah

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 115 KB

english, 2011

86

Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: Implications for cancer risk reduction

F. Linkov, D. Bovbjerg, J. Delany, B. Goodpaster, J. Jakicic, D. Lenzner, Y. Lin, G. Maxwell, A. Felix, A. Lokshin

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 100 KB

english, 2011

87

Performance of implementing guideline-driven cervical cancer screening Measures in an Inner-City Hospital System

E. Wu, D. Wieland, L. Reimers, E. Burton, T. Gruenberg, M. Abadi, M. Einstein

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 184 KB

english, 2011

88

Significant endometrial pathology detected during a transvaginal ultrasound screening trial for ovarian cancer

R. Woolas, A. Talaat, M. Anderson, D. Brinkmann, F. Gardner, A. Gentry-Maharaj, A. Ryan, A. Rosenthal, U. Menon, I. Jacobs

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 117 KB

english, 2011

89

Women with invasive gynecologic malignancies are more than 12 times as likely to commit suicide as are women in the general population

K. Ward, A. Roncancio, S. Plaxe

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 119 KB

english, 2011

90

Additional data from a study of lymphatic mapping and sentinel node identification in early-stage cervical cancer

L. Rob, M. Halaska, M. Komar, M. Pluta, H. Robova, P. Skapa

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

91

Secondary cytoreductive surgery: A key tool in the management of recurrent ovarian sex cord–stromal tumors

D. Namaky, P. Ramirez, M. Munsell, A. Nick, D. Gershenson, J. Brown

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

92

Sentinel lymph node mapping in patients with endometrial cancer undergoing robot-assisted or standard laparoscopic procedures

M. Leitao, F. Khoury Collado, G. Gardner, E. Jewell, C. Brown, Y. Sonoda, D. Levine, R. Barakat, N. Abu-Rustum

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 67 KB

english, 2011

93

Short- and long-term morbidity and outcomes after robotic surgery for endometrial cancer staging

F. Backes, L. Brudie, M. Farrell, S. Ahmad, N. Finkler, G. Bigsby, D. O'Malley, D. Cohn, R. Holloway, J. Fowler

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

94

7-Methyl indole ethyl isothiocyanate: A novel cytotoxic agent for endometrial cancer

K. Kristjansdottir, R. Singh, K. Kim, T. Lange, L. Brard

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

95

A novel hedgehog pathway smoothened inhibitor (BMS-833923) demonstrates in vitro synergy with carboplatin in ovarian cancer cells

R. Rocconi, E. Meng, L. Shevde, M. Finan, E. Reed

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 67 KB

english, 2011

96

Ab-IL2 fusion proteins mediate NK cell immune synapse formation in epithelial ovarian cancer by polarizing CD25 to the target cell–effector cell interface

J. Connor, I. Buhtoiarov, S. Gillies, J. Gubbels, J. Hank, P. Sondel, A. Kapur, M. Patankar

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

97

Activating PIK3CA and RAS mutations identified exclusively in carcinosarcomas of uterine origin

W. Growdon, L. Garrett, B. Rousel, V. Scialabba, L. Ellisen, D. Dias-Santagata, R. Foster, R. Tambouret, B. Rueda, D. Borger

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 67 KB

english, 2011

98

AMPK activation mimics glucose deprivation and induces cytotoxicity in ovarian cancer cells

J. Liu, A. Priebe, L. Tan, H. Wahl, A. Opipari, R. Kwok

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

99

Antiproliferative activity of a phenolic extract from a native Chilean Amaranthaceae plant in drug-resistant ovarian cancer cell lines

J. Brouwer-Visser, M. Cossio, N. Urzùa, G. Montenegro, S. Horwitz, R. Moreno, G. Huang

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

100

Association between global DNA hypomethylation in leukocytes and risk of ovarian cancer

S. Akers, K. Moysich, W. Zhang, P. Link, A. Miller, S. Lele, K. Odunsi, A. Karpf

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 103 KB

english, 2011

101

Cisplatin, carboplatin, and paclitaxel: Unique and common pathways that underlie ovarian cancer response

E. Bicaku, Y. Xiong, D. Marchion, X. Stickles, J. Gonzalez-Bosquet, R. Wenham, J. Lancaster

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 85 KB

english, 2011

102

Clinical significance of vascular cell adhesion molecule 1 in the ovarian cancer microenvironment

J. Scalici, C. Harrer, K. Atkins, A. Jazaeri, L. Duska, J. Slack-Davis

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 172 KB

english, 2011

103

Combined erbB/VEGFR blockade has improved anticancer activity over single-pathway inhibition in ovarian cancer in vivo

T. Farzan, S. Harrington, J. Krempski, S. Weroha, X. Hou, K. Kalli, P. Haluska

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 119 KB

english, 2011

104

Comparison of mTOR and HIF pathway alterations in the clear cell carcinoma variant of kidney, ovary and endometrium

Z. Al-Wahab, R. Morris, A. Semaan, L. Solomon, S. Munns, S. Seward, R. Ali-Fehmi, A. Munkarah

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 134 KB

english, 2011

105

Concordant gene expression profiles in matched primary and recurrent serous ovarian cancers predict platinum response

G. Sfakianos, J. Yan, R. Whitaker, S. Murphy, A. Berchuck

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 46 KB

english, 2011

106

Cooperative regulation of hPygo2 biomarker expression in cervical dysplasia and cancer

C. Popadiuk, K. Kao, Y. Tzenov

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 242 KB

english, 2011

107

Detection of the tissue-derived biomarker peroxiredoxin 1 in serum of patients with ovarian cancer: A biomarker feasibility study

E. Hoskins, B. Hood, M. Sun, T. Krivak, T. Conrads, R. Edwards

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 228 KB

english, 2011

108

Differential gene expression in endometrium, abdominal wall adipose tissue and omentum in obese women with and without endometrial cancer

S. Modesitt, J. Hsu

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 246 KB

english, 2011

109

Differential microRNA expression in cis-platinum-resistant versus -sensitive ovarian cancer cell lines

A. Sherman, L. Hu, C. Melton, D. Kapp, J. Chan

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

110

DNA methylation markers associated with serous ovarian cancer subtypes

U. Chandavarkar, M. Campan, S. Houshdaran, C. Pearce, H. Shen, M. Widschwendter, A. Berchuck, L. Roman, P. Laird

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

111

Epithelial ovarian cancer tumor microenvironment is a favorable biomarker resource

E. Hoskins, B. Hood, M. Sun, T. Krivak, T. Conrads, R. Edwards

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 113 KB

english, 2011

112

EZH2 expression correlates with increased angiogenesis in ovarian carcinoma

R. Ali-Fehmi, Z. Al-Wahab, A. Semaan, S. Seward, R. Morris, A. Munkarah, A. Sood

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 93 KB

english, 2011

113

Identification and characterization of CD44+/CD24–ovarian cancer stem cell properties and their correlation with survival

E. Meng, L. Shevde, B. Long, P. Sullivan, S. McClellan, M. Finan, E. Reed, R. Rocconi

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 113 KB

english, 2011

114

Induction of apoptosis in cisplatin-resistant ovarian cancer cells by G-1, a specific agonist of the G-protein-coupled estrogen receptor GPR30

T. Nguyen, E. Ariazi, E. Brailoiu, G. Brailoiu, J. Taylor, J. Boyd

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

115

Insulin promotes proliferation and carcinogenesis of normal endometrial cells

E. Bishop, S. Lightfoot, D. Benbrook

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

116

MicroRNA and messenger RNA pathways associated with ovarian cancer cell sensitivity to topotecan, gemcitabine and doxorubicin

X. Stickles, E. Bicaku, D. Marchion, N. Chen, Y. Xiong, J. Gonzalez Bosquet, R. Wenham, S. Apte, J. Lancaster

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 67 KB

english, 2011

117

Molecular profiling of patients with curatively treated advanced serous ovarian carcinoma from The Cancer Genome Atlas

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 46 KB

english, 2011

118

Neuropilin-1 blockade in the tumor microenvironment reduces tumor growth

A. Nick, R. Stone, J. Bottsford-Miller, W. Spannuth, N. Jennings, A. Bagri, R. Coleman, A. Sood

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

119

Ovarian cancer lymph node metastases express unique cellular structure and adhesion genes

M. Spillman, N. Manning, W. Dye, K. Horwitz

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

120

Overexpression of fibroblast growth factor 1 and fibroblast growth factor receptor 4 in high-grade serous ovarian carcinoma: Correlation with survival and implications for therapeutic targeting

T. Zaid, M. Thompson, K. Wong, T. Yeung, Z. Yeung, S. Kwan, C. Co, R. Schmandt, M. Birrer, S. Mok

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

121

Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: A conserved regulatory mechanism important in tumorigenesis?

Y. Ioffe, K. Chiappinelli, P. Pollock, M. Powell, I. Zighelboim, P. Thaker, D. Mutch, P. Goodfellow

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 120 KB

english, 2011

122

Proteasome inhibition increases death receptors and decreases major histocompatibility complex I expression: Pathways to exploit in natural killer cell immunotherapy

M. Geller, L. Priby, L. Rogers, J. Miller

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 101 KB

english, 2011

123

Proteomic analysis demonstrates that BRCA1-deficient epithelial ovarian cancer cell lines activate alternative pathways following exposure to cisplatin

J. Lesnock, B. Hood, M. Sun, B. Teng, B. Rungruang, M. Flint, T. Krivak, T. Conrads

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 294 KB

english, 2011

124

Quantitative PCR array identification of microRNA clusters associated with epithelial ovarian cancer chemoresistance

D. Fishman, F. Wang, A. DiFeo, G. Narla

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 225 KB

english, 2011

125

Stop and smell the volatile organic compounds: A novel breath-based bioassay for detection of ovarian cancer

A. Nick, R. Stone, J. Bottsford-Miller, P. Ramirez, C. Tung, G. Armaiz-Pena, E. Felix, A. Sood

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 242 KB

english, 2011

126

Stress and the metastatic switch in epithelial ovarian carcinoma

M. Shahzad, J. Arevalo, R. Stone, G. Armaiz-Pena, J. Bottsford-Miller, A. Nick, S. Lutgendorf, G. Lopez-Berestein, S. Cole, A. Sood

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

127

Targeting the hedgehog pathway reverses taxane resistance in ovarian cancer

A. Ziebarth, A. Steg, K. Bevis, A. Katre, R. Alvarez, C. Landen

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 124 KB

english, 2011

128

The cytoskeletal gateway for tumor aggressiveness in ovarian cancer is driven by class III β-tubulin

C. Ferlini, M. Mariani, S. Shahabi

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 109 KB

english, 2011

129

The pattern of H3K56 acetylation expression in ovarian cancer

A. Liu, A. Wilson, T. Edwards, M. Williams, E. Holson, S. Bhaskara, S. Hiebert, J. Slaughter, O. Fadare, D. Khabele

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 126 KB

english, 2011

130

The tumor suppressor KLF6, lost in a majority of ovarian cancer cases, represses VEGF expression levels

W. Bradley, P. Dottino, J. Rahaman, A. DiFeo, J. Martignetti

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

131

Thinking outside of the tumor: Targeting the ovarian cancer microenvironment

J. Scalici, C. Harrer, K. Atkins, K. McLachlan, L. Duska, J. Slack-Davis

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

132

True blood: Platelets as a biomarker of ovarian cancer recurrence

J. Bottsford-Miller, S. Lutgendorf, C. Pecot, R. Stone, A. Nick, K. Matsuo, E. King, K. Ring, K. De Geest, A. Sood

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 66 KB

english, 2011

133

Tumor expression of the type I insulin-like growth factor receptor is an independent prognostic factor in epithelial ovarian cancer

G. Huang, T. Hebert, C. Kim, J. Lin, H. Arias-Pulido, H. Smith

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

134

Compliance with recommended genetic counseling for Lynch syndrome: Room for improvement

F. Backes, E. Mitchell, H. Hampel, D. Cohn

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 65 KB

english, 2011

135

Does genetic counseling for women at high risk of harboring a deleterious BRCA mutation alter risk-reduction strategies and cancer surveillance behaviors?

M. Henretta, A. Askew, M. Smolkin, E. Guffey, S. Modesitt, W. Cohn, M. Ropka

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

136

Hereditary breast and ovarian cancer syndrome based on family history alone and implications for patients with serous carcinoma

K. Long, E. Tanner, N. Kauff, L. Krill, M. Leitao, D. Levine, E. Jewell, R. Barakat, D. Chi

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

137

Management and clinical outcomes of women with BRCA1/2 mutations found to have occult cancers at the time of risk-reducing salpingo-oophorectomy

D. Iglesias, C. Sun, C. Langstraat, J. Bakkum-Gamez, S. El-Nashar, E. Keeler, D. Gershenson, K. Lu

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 267 KB

english, 2011

138

RNASeq identifies germline and tumor-specific mutations in a hereditary cervical cancer syndrome: Successful proof-of-principle study for gynecologic cancer gene discovery

R. Mosig, E. Senturk, H. Shah, S. Cohen, R. Sachidanandam, C. Eliasen, M. Glucksman, M. Chee, P. Dottino, J. Martignetti

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 250 KB

english, 2011

139

The impact of BRCA testing on surgical treatment decisions for patients with breast cancer

K. Doll, W. Gradishar, J. Trosman, C. Weldon, J. Schink

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 267 KB

english, 2011

140

Utility of symptom index in women at increased risk for ovarian cancer

D. Singh, K. Lowe, C. Colllins, L. Cohen, J. Dungan, L. Shulman, M. Andersen, B. Goff

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

141

EZH2 expression in triple-negative breast carcinoma

Z. Al-Wahab, A. Munkarah, S. Munns, S. Seward, A. Sood, R. Morris, R. Ali-Fehmi

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 68 KB

english, 2011

142

Incidental gynecologic FDG-PET/CT findings in women with a history of breast cancer

T. Pua, A. Jewell, A. Novetsky, J. Lee, K. Friedman, J. Whyte, L. Boyd, B. Pothuri, J. Curtin, S. Blank

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

143

Accuracy of frozen-section diagnosis of ovarian borderline tumor

K. Shih, K. Garg, R. Soslow, D. Chi, N. Abu-Rustum, R. Barakat

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

144

Advanced-stage ovarian cancer metastases to sigmoid colon mesenteric lymph nodes: Clinical consideration of tumor spread and biologic behavior

M. Peiretti, P. Rosenberg, G. Aletti, N. Colombo, L. Bocciolone, F. Landoni, V. Zanagnolo, A. Maggioni

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 109 KB

english, 2011

145

C-terminal binding protein 2: A potential marker for response to histone deacetylase inhibitors in epithelial ovarian cancer

L. Barroilhet, J. Yang, K. Hasselblatt, J. Rauh-Hain, W. Welch, R. Berkowitz, S. Ng

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 92 KB

english, 2011

146

CA-125 changes can predict optimal interval cytoreduction in patients with advanced-stage epithelial ovarian cancer treated with neoadjuvant chemotherapy

N. Rodriguez, J. Rauh-Hain, C. Feltmate, M. Del Carmen, R. Penson, A. Goodman, U. Matulonis, M. Muto, J. Schorge, N. Horowitz

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 108 KB

english, 2011

147

CA-125 surveillance for women with ovarian, fallopian tube or primary peritoneal cancers: What do survivors think?

L. Boyd, S. Bedell, J. Curtin, R. Wallach, B. Pothuri, F. Muggia, A. Tiersten, S. Blank

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

148

Calretinin as a prognostic indicator in granulosa cell tumor

H. Arabi, R. Ali-Fehmi, L. Solomon, Z. Al-Wahab, A. Semaan, S. Bandyopadhyay, A. Munkarah, R. Morris

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 123 KB

english, 2011

149

Carcinosarcoma of the ovary: A case–control study

J. Rauh-Hain, W. Growdon, N. Rodriguez, A. Goodman, J. Schorge, D. Boruta, N. Horowitz, M. Del Carmen

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 107 KB

english, 2011

150

Changes in tumor blood flow as estimated by dynamic-contrast MRI may predict activity of single-agent bevacizumab in recurrent epithelial ovarian cancer and primary peritoneal cancer: An exploratory analysis of a Gynecologic Oncology Group phase II trial

D. Chase, M. Sill, M. Chambers, K. Darcy, E. Han, J. Fruehauf, B. Monk, B. Buening, J. Sorosky, R. Burger

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 124 KB

english, 2011

151

Comparing overall survival in patients with epithelial ovarian, primary peritoneal or fallopian tube cancer who received chemotherapy alone versus neoadjuvant chemotherapy followed by delayed primary debulking

R. Correa, S. Dunningan, T. Panzarella, S. Ferguson, K. Murphy, H. Mackay, M. Bernardini

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

152

Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced ovarian cancer

J. Lesnock, C. Farris, T. Krivak, K. Smith, M. Markman

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 303 KB

english, 2011

153

Cytoreductive surgery for serous ovarian cancer in patients 75 years and older

K. Long, E. Tanner, M. Guy, M. Leitao, G. Gardner, Y. Sonoda, C. Brown, R. Barakat, D. Chi

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 286 KB

english, 2011

154

Discovery of novel monoclonal antibodies (MC1–MC6) to detect ovarian cancer in serum and differentiate it from benign tumors

E. Orr, D. Vassilakos, A. Gonenne, B. Piura, A. Rabinowich, T. Van Gorp, I. Vergote

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 290 KB

english, 2011

155

Elevated serum adiponectin levels correlate with survival in epithelial ovarian cancers

E. Diaz, I. Chen, N. Liburd, B. Karlan, C. Walsh, I. Cass, A. Li

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

156

Evaluation of the risk of ovarian malignancy algorithm in women with a pelvic mass presenting to general gynecologists

R. Moore, C. Miller, P. DiSilvestro, L. Landrum, W. Gajewski, P. Renneisen, S. Skates

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

157

Factors associated with hospice use in ovarian cancer

C. Casey, H. Deshmukh, A. Sherman, L. Chen, J. Chan

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 69 KB

english, 2011

158

Genes functionally regulated by methylation in ovarian cancer are involved in cell proliferation, development and morphogenesis

K. Yamaguchi, T. Baba, I. Konishi, N. Matsumura, S. Murphy, Z. Huang, A. Berchuck

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

159

Horm-A domain-containing protein 1 (HORMAD1) and outcomes in patients with ovarian cancer

M. Shahzad, K. Matsuo, Y. Shin, R. Stone, J. Bottsford-Miller, C. Lu, H. Han, A. Rajkovic, A. Sood

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

160

Human epididymis protein 4 increases specificity for the detection of invasiive epithelial ovarian cancer in premenopausal women presenting with an adnexal mass

K. Holcomb, C. Miller, Z. Vucetic, R. Knapp

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 66 KB

english, 2011

161

Identification of biomarkers to improve specificity in preoperative assessment of ovarian tumor for risk of cancer

Z. Zhang, L. Sokoll, X. Sun, D. Meany, D. Elliott, D. Chan

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

162

Impact of FDG-PET in suspected recurrent ovarian cancer and optimization of patient selection for cytoreductive surgery

Y. Ebina, N. Sakuragi

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 108 KB

english, 2011

163

Influence of the novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer

L. Garrett, L. Zhang, L. Guo, V. Therrien, W. Growdon, R. Foster, B. Rueda

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 93 KB

english, 2011

164

Inhibition of stress-induced phosphoprotein 1 decreases proliferation of ovarian cancer cell lines

B. Kim, J. Kim, Y. Kim, S. Kim, S. Kim, E. Nam, D. Chay

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 93 KB

english, 2011

165

Insulin-like growth factor receptor 1 pathway signature correlates with adverse clinical outcome in ovarian cancer

B. Winterhoff, P. Haluska, K. Kalli, W. Cliby, B. Gostout, A. Oberg, M. Maurer, L. Hartmann, D. Slamon, G. Konecny

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 108 KB

english, 2011

166

Intraperitoneal catheters placed at the time of bowel surgery: A review of complications

J. Carter, E. Dickson, R. Kothari, L. Downs, P. Argenta

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

167

Laparoscopic versus laparotomic surgical staging for early-stage epithelial ovarian cancer

J. Park, D. Kim, J. Kim, Y. Kim, Y. Kim, J. Nam

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

168

Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as treatment for borderline ovarian tumor

T. Song, D. Bae, C. Choi, H. Kim, M. Kim, T. Kim, B. Kim, Y. Lee, J. Lee, J. Lee

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

169

OVA1 has high sensitivity in identifying ovarian malignancy compared with preoperative assessment and CA-125

F. Ueland, C. DeSimone, L. Seamon, R. Miller, S. Goodrich, I. Podzielinski, L. Sokoll, A. Smith, J. van Nagell, Z. Zhang

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

170

OVA1 improves the sensitivity of the ACOG referral guidelines for an ovarian mass

R. Miller, A. Smith, C. DeSimone, L. Seamon, S. Goodrich, I. Podzielinski, J. van Nagell, Z. Zhang, F. Ueland

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 65 KB

english, 2011

171

Peritoneal staging biopsies in early-stage ovarian cancer: Are they necessary?

R. Kothari, J. Carter, M. Geller

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

172

Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer

R. Laskey, M. Poniewierski, M. Lopez, R. Hanna, A. Alvarez-Secord, P. Gehrig, G. Lyman, L. Havrilesky

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 105 KB

english, 2011

173

Prognostic impact of prechemotherapy HE4 and CA-125 levels in patients with ovarian cancer

K. Dahl Steffensen, M. Waldstrøm, I. Brandslund, A. Jakobsen

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 93 KB

english, 2011

174

Revisiting the issue of race-related outcomes in patients with stage IIIC papillary serous ovarian cancer who receive similar treatment

O. Ibeanu, S. Ueda, M. Gerardi, R. Bristow

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

175

Sequencing of therapy and outcomes associated with use of neoadjuvant chemotherapy in advanced epithelial ovarian cancer in the Medicare population

M. Thrall, H. Gray, R. Symons, D. Flum, N. Weiss, B. Goff

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

176

Serum HE4 level is an independent risk factor of surgical outcome and prognosis of epithelial ovarian cancer

S. Kang, S. Kong, S. Park, S. Seo, J. Kim

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 103 KB

english, 2011

177

Should we treat patients with ovarian cancer with positive retroperitoneal lymph nodes with intraperitoneal chemotherapy? Impact of lymph node status in women undergoing intraperitoneal chemotherapy

H. Gray, M. Thrall, H. Tamimi, R. Swensen, R. Garcia, B. Goff

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 107 KB

english, 2011

178

Significance of perioperative infectious disease in patients with ovarian cancer

K. Matsuo, C. Prather, E. Ahn, M. Eno, D. Im, N. Rosenshein, A. Yessaian, Y. Lin

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 94 KB

english, 2011

179

Single-nucleotide polymorphism in DNA repair and drug resistance genes alone or in combination in epithelail ovarian cancer

J. Connor, J. Kolesar

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 94 KB

english, 2011

180

Sonographic predictors of ovarian malignancy

L. Barroilhet, B. Benacerraf, T. Shipp, A. Vitonis, M. Muto

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 108 KB

english, 2011

181

STAC: A phase II study of carboplatin/paclitaxel/bevacizumab followed by randomization to either bevacizumab alone or erlotinib and bevacizumab in the upfront management of patients with ovarian, fallopian tube or peritoneal cancer

S. Campos, T. Atkinson, S. Berlin, M. Roche, C. Whalen, U. Matulonis, N. Horowitz, M. Birrer, R. Penson

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

182

Symptom-triggered screening for ovarian cancer: A pilot study of feasibility and acceptability

B. Goff, K. Lowe, J. Kane, M. Robertson, M. Gaul, M. Andersen

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 109 KB

english, 2011

183

The feasibility of mediastinal lymphadenectomy in the management of advanced and recurrent ovarian carcinoma

J. Diaz, B. Park, J. Stine, R. Flores, Y. Sonoda, N. Abu-Rustum, R. Barakat, D. Chi

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 93 KB

english, 2011

184

The impact of diabetes on survival in women with ovarian cancer

A. Bakhru, J. Griggs, R. Buckanovich

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 93 KB

english, 2011

185

Women without ovarian cancer reporting disease-specific symptoms

E. Pavlik, C. DeSimone, R. Miller, I. Podzielinski, J. Ubellacker, S. Goodrich, F. Ueland, L. Seamon, R. Kryscio, J. van Nagell

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 110 KB

english, 2011

186

A cost analysis of postoperative pain management in patients with endometrial cancer: Robotics versus laparoscopy

M. Martino, S. Kimmel, R. Miller, J. Schindler, J. Shubella, S. Williams, M. Thomas, R. Boulay

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

187

A longitudinal evaluation of sexual functioning and quality of life in cervical cancer survivors

D. Bodurka, C. Sun, A. Jhingran, D. Urbauer, C. Levenback, P. Eifel, L. Ramondetta, P. Ramirez, M. Frumovitz, L. Schover

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 68 KB

english, 2011

188

Age-related preferences regarding end-of-life care discussions among gynecologic oncology patients

A. Brown, M. Johnson, R. Giuntoli, T. Diaz-Montes

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

189

Menopausal symptoms and use of hormone replacement therapy: The gynecologic cancer survivors' perspective

M. Huang, S. Westin, C. Sun, L. Meyer, C. Tung, D. Urbauer, D. Bodurka

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

190

Palliative care education in gynecologic oncology: A survey of the fellows

J. Lesnock, R. Arnold, L. Meyn, M. Buss, M. Quimper, T. Krivak, R. Edwards, J. Chang

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 69 KB

english, 2011

191

Pegylated liposomal doxorubicin with bevacizumab in the treatment of platinum-resistant ovarian cancer: Toxicity profile results

S. Czok, A. Jewell, S. Shawki, L. Boyd, H. Smith, S. Blank, C. Muller, C. Verschraegen, F. Muggia

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

192

Phase II Trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy

R. Wenham, J. LaPolla, L. Hui-Yi, S. Apte, W. Roberts, J. Lancaster, J. Gonzalez Bosquet, S. Theodore, L. Havrilesky, A. Alvarez-Secord

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 68 KB

english, 2011

193

A phase I/II trial of IDD-6, an autologous dendritic cell vaccine for women with advanced ovarian cancer in remission

C. Chu, J. Boyer, P. Gimotty, S. Rubin, G. Coukos, M. Morgan, J. Bender, C. June

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 54 KB

english, 2011

194

Abnormal cervical cytology in the preoperative diagnosis of uterine papillary serous carcinoma: Earlier detection of a poor prognostic uterine cancer?

M. Skaznik-Wikiel, S. Ueda, A. Fleury, H Frasure, F. Grumbine, P. Rose, A. Nickles Fader

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 68 KB

english, 2011

195

Adiposity and endometrial cancer: The stress of excess

K. Matsuo, S. Srivastava, P. Tripathi, L. Sonoda, E. Yoo, K. Pfaffenbac, L. Dubeau, A. Lee, Y. Lin

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

196

Analysis of risk factors for isolated paraaortic lymph node metastasis in endometrial cancer: A clinicopathologic study of 210 consecutive patients

S. Chang, W. Kim, T. Kong, S. Yoo, J. Yoon, K. Chang, H. Ryu

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 64 KB

english, 2011

197

Complete gross resection is associated with improved survival in advanced-stage uterine carcinosarcoma

E. Tanner, G. Gardner, Y. Sonoda, K. Garg, D. Chi, M. Leitao, E. Jewell

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

198

Distribution of extrauterine disease in uterine papillary serous carcinoma: Is minimally invasive surgery a suitable approach?

T. Ayeni, M. Al Hilli, A. Mariani, M. McGree, A. Weaver, W. Cliby, K. Podratz, S. Dowdy

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

199

Early-stage high-risk endometrial cancer: Adjuvant treatment with chemotherapy and vaginal brachytherapy

S. Schuman, J. Stine, W. Zhao, P. Yali, A. Wolfson, J. Lucci

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 61 KB

english, 2011

200

Evaluation of intrauterine progesterone for the treatment of complex atypical hyperplasia and low-grade endometrial cancer

M. Billow, L. Nieves-Arriba, R. DeBernardo

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

201

Fertility-sparing management with progestin for young women with stage I endometrioid endometrial cancer: Long-term outcomes

J. Park, D. Kim, J. Kim, Y. Kim, Y. Kim, J. Nam

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 63 KB

english, 2011

202

Hysterectomy for uterine adenocarcinoma in the oldest old: Tumor characteristics and long-term outcome

O. Gayar, J. Robbins, K. Parikh, M. Lu, T. Buekers, A. Munkarah, M. Elshaikh

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

203

Incidence and salvage rates of isolated vaginal recurrence in uterine papillary serous carcinoma

K. Zanotti, P. Rose, P. Gehrig, K. Moore, H. Frasure, L. Havrilesky, A. Alvarez-Secord, W. Huh, D. OMalley, A. Nickles Fader

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

204

Indole-3-carbinol supplements in obese women: Chemoprevention or carcinogenic?

J. Connor, S. Fleming, N. Onujiogu

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

205

Laparoscopic surgery for endometrial cancer: Why don't all patients go home the day after surgery?

R. Spencer, J. Schorge, M. Del Carmen, A. Goodman, W. Growdon, D. Boruta

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

206

Laparoscopic surgery versus laparotomy in the management of early endometrial cancer: Long-term follow-up outcomes

S. Park, J. Park, D. Kim, J. Kim, Y. Kim, Y. Kim, J. Nam

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 122 KB

english, 2011

207

Location versus extent of nodal metastasis in node-positive uterine cancer: Which is more prognostic?

R. Urban, M. DeChant, T. Kiet, R. Brooks, S. Ueda, L. Chen, D. Kapp, J. Chan

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 105 KB

english, 2011

208

Novel brachytherapy device design for treatment of cervical and uterine carcinoma

D. Scanderbeg, C. Saenz, S. Plaxe, M. McHale, E. Alvarez, C. Yashar

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 181 KB

english, 2011

209

Outcome assessment following treatment of isolated lymphatic recurrences in patients with endometrial cancer

S. Kumar, K. Podratz, W. Cliby, S. Dowdy, A. Mariani

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 107 KB

english, 2011

210

Platinum sensitivity as a predictor of outcome in recurrent endometrial carcinoma

B. Erickson, K. Bevis, H. Smith, R. Alvarez

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 123 KB

english, 2011

211

Reliability of frozen-section examination in endometrial carcinoma at a tertiary care center: Is it appropriate for intraoperative guidance of treatment decisions?

A. Mariani, F. Medeiros, S. Dowdy, K. Podratz, J. Bakkum-Gamez, W. Cliby, A. Weaver, M. McGree, G. Keeney

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

212

Reverse-phase protein lysate array identified potential therapeutic targets in uterine carcinosarcoma

E. Euscher, C. Wei, L. Ramondetta, R. Broaddus

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

213

Risk factors for future development of endometrial cancer in patients with benign endometrial biopsy: Epidemiologic study from the Olmsted County population

M. Torres, A. Weaver, W. Cliby, S. Dowdy, F. Abimbola, S. Uccela, B. Gostout, A. Mariani

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

214

Risk factors for thromboembolism within the first 30 days of endometrial cancer surgery

S. Kumar, K. Podratz, S. Dowdy, J. Bakkum-Gamez, A. Weaver, M. McGree, J. Martin, W. Cliby, A. Mariani

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

215

Secondary cytoreductive surgery for recurrent endometrial cancer

C. McCann, L. Bradford, D. Boruta, M. Del Carmen, A. Goodman, W. Growdon, J. Schorge

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 63 KB

english, 2011

216

Sentinel lymph node mapping for grade 1/2 endometrial cancer with superficial myoinvasion: Less is more

F. Khoury Collado, M. Murray, M. Hensley, Y. Sonoda, J. Gomez, D. Levine, M. Leitao, D. Chi, R. Barakat, N. Abu-Rustum

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

217

Sequential chemotherapy and radiation therapy for the adjuvant treatment of uterine papillary serous carcinoma

V. Kolev, R. Zhang, W. Bradley, R. N'gouamba, P. Dottino, J. Rahaman, M. Hayes

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

218

Surgical staging for endometrial cancer in the elderly: Is there a role for lymphadenectomy?

W. Lowery, P. Gehrig, E. Ko, A. Alvarez-Secord, J. Chino, L. Havrilesky

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 137 KB

english, 2011

219

Survival outcomes for women with uterine malignancy undergoing robot-assisted laparoscopic staging procedures

L. Brudie, F. Backes, S. Ahmad, N. Finkler, G. Bigsby, D. Cohn, D. O'Malley, M. Farrell, J. Fowler, R. Holloway

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 122 KB

english, 2011

220

The impact of postoperative therapy on the survival of patients with uterine serous carcinoma

R. Jalloul, Z. Al-Wahab, R. Ali-Fehmi, M. Elshaikh, M. Cote, T. Buekers, R. Morris, A. Munkarah

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 138 KB

english, 2011

221

The incidence of endometrial pathology and the effects of weight loss in asymptomatic women undergoing bariatric surgery: A prospective, natural history study

P. Argenta, M. Kassing, D. Brooker, A. Truskinovsky, C. Svendsen

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

222

The prognostic significance of lymphovascular space invasion in laparoscopic versus abdominal hysterectomies for endometrioid endometrial cancer

S. Dewdney, Z. Jiao, A. Roma, F. Gao, B. Rimel, P. Thaker, M. Powell, L. Massad, D. Mutch, I. Zighelboim

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

223

The transforming growth factor β signaling pathway in endometrial cancer: Expression and clinical significance

J. Kesterson, D. Wang, S. Akers, N. duPont, K. Clark, S. Lele, S. Liu, P. Mhawech-Fauceglia

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

224

Usefulness of serial CA-125 levels in surveillance of endometrial cancer

K. Pennington, R. Reynolds

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

225

A phase I clinical trial of the mTOR inhibitor everolimus in combination with oral topotecan for patients with recurrent and advanced endometrial cancer

M. Abu-Khalaf, A. Santin, E. Ratner, D. Silasi, K. ElSahwi, L. Baker, M. Luther, M. Azodi, T. Rutherford, P. Schwartz

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 111 KB

english, 2011

226

Is it more cost-effective to use bevacizumab in the primary treatment setting or at recurrence? An economic analysis

K. Fuh, J. Chan, B. Monk, R. Urban, L. Hu, D. Kapp, A. Caughey, X. Yu

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 93 KB

english, 2011

227

Predictors and effects of reduced relative dose intensity in women receiving their primary course of chemotherapy for ovarian cancer

R. Hanna, M. Poniwierski, R. Laskey, M. Lopez, A. Shafer, P. Gehrig, A. Alvarez-Secord, L. Havrilesky, G. Lyman

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 97 KB

english, 2011

228

Therapeutic synergy and resensitization of drug-resistant ovarian carcinoma to cisplatin by HO-3867

K. Selvendiran, S. Ahmed, A. Dayton, M. Kuppusamy, T. Kálai, K. Hideg, P. Kuppusamy

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

229

Attrition of first-time faculty in gynecologic oncology: Is there a difference between men and women?

T. Rutledge, C. Muller, R. Schrader, Y. Gener, A. Fullilove, W. Rayburn

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

230

Clinical value and efficacy of surveillance in patients with early-stage endometrial cancer

R. Salani, E. Drennen, C. Nagel, R. Bristow

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 67 KB

english, 2011

231

Disparities in gynecologic oncologist care in patients with endometrial cancer in the United States

R. Ruskin, H. Deshmukh, D. Kapp, S. Ueda, L. Chen, T. Kiet, A. Husain, J. Chan

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

232

Have PORTEC 1 and GOG 99 changed practice patterns in the United States?

E. Ko, M. Funk, W. Brewster

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

233

Incidence of venous thromboembolism after robotic surgery for gynecologic malignancy: Is dual prophylaxis necessary?

J. Embry, K. Davis, N. Mejia, S. Davidson, M. Kelly, K. Behbakht

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 64 KB

english, 2011

234

Is extended prophylaxis with low-molecular-weight heparin necessary in patients with endometrial cancer undergoing minimally invasive robotic surgery?

N. Neubauer, E. Chapman-Davis, R. Scott-Ram, J. Lurain, J. Schink, M. Lowe

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

235

Management of complex pelvic masses using the OVA1 test: A decision analysis

G. Zsebik, K. Kim, J. Straughn, C. Landen

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 63 KB

english, 2011

236

Relative impact of cost drivers on the increasing expense of inpatient gynecologic oncology care

S. Plaxe, L. Prellwitz

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

237

Repeat excisional cervical procedures in older women: Is there an age at which cold knife cone should be performed rather than in-office LEEP?

E. Nugent, C. Barr, K. Moxley, J. Strebel, K. Moore

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

238

The use of bevacizumab and cytotoxic and consolidation chemotherapy for the upfront treatment of advanced ovarian cancer: Practice patterns among medical and gynecologic oncology SGO members

J. Elder, M. Mattingly, A. Ferda, C. DeSimone, R. Ware, F. Ueland, J. van Nagell, J. Carlson, L. Seamon

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

239

Three-dimensional power doppler angiography as a three-step technique for differential diagnosis of adnexal masses: A prospective study

M. Jurado, J. Alcazar, M. Auba, A. Ruiz-Zambrana

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

240

Uterine leiomyosarcoma: Can locoregional recurrences be salvaged by surgery and additional therapies?

K. Levinson, E. Eisenhauer, P. Gehrig, A. Suri, M. Tenney, H. Frasure, L. Havrilesky, M. Lopez, A. Alvarez-Secord, A. Nickles Fader

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 68 KB

english, 2011

241

2008 FIGO stage IIA1 and IIA2 cervical cancer: Does the new staging system predict survival and/or lymph node metastasis?

G. Garg, J. Shah, R. Morris

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

242

Adenocarcinoma as an independent risk factor for early-stage intermediate-risk cervical carcinoma

C. Mathews, S. Goodrich, R. Farrell, C. DeSimone, L. Seamon, L. Landrum

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 146 KB

english, 2011

243

Can LEEP replace cold knife conization for the management of cervical intraepithelial neoplasia in women with unsatisfactory colposcopic examination? A systematic review and a meta-analysis

S. El-Nashar, M. Hopkins, W. Cliby, A. Famuyide

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 131 KB

english, 2011

244

Chromosome 3q26 gain for identification of women less likely to progress from LSIL/CIN 1 to HSIL/≥CIN 2

A. Rodolakis, J. Biliatis, N. Thomakos

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

245

Completed versus aborted radical hysterectomy for node-positive stage I cervical cancer

A. Ziebarth, J. Durst, A. Subramaniam, N. Nguyen, H. Smith, E. Killian, K. Kim, C. Leath, J. Straughn, R. Alvarez

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

246

Consequences of lengthening cervical cancer screening intervals on mammography rates

H. Dinkelspiel, T. Flanagan, W. Kinney, B. Fetterman, T. Lorey, P. Castle

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 67 KB

english, 2011

247

Effect of surgeon and hospital volumes on outcome for women undergoing radical hysterectomy for cervical cancer

J. Wright, S. Lewin, I. Deutsch, X. Sun, W. Burke, T. Herzog

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

248

Genetic polymorphisms of the transporter associated with antigen processing are associated with cervical neoplasia in Korean women

N. Kim, S. Chung, S. Lee, W. Ju, S. Kim

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 54 KB

english, 2011

249

Implementation of surgical treatment for early-stage cervical cancer by Kenyan gynecologists in western Kenya

B. Rosen, O. Elkanah, P. Itsura, C. Giede, W. Jimenezfiedler, S. Sinasac, P. Cibulska, D. Miller, L. Elit, J. Dodge

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

250

Intraoperative detection of nodal metastasis in early-stage cervical cancer: A survey of the practice patterns of SGO members

G. Garg, J. Shah, E. Toy, J. Field, C. Bryant, R. Morris

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

251

Is there a microinvasive cervical adenocarcinoma?

L. Spoozak, S. Lewin, W. Burke, I. Deutsch, X. Sun, T. Herzog, J. Wright

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 66 KB

english, 2011

252

Late toxicity of chemoradiotherapy: An underrecognized source of morbidity in survivors of locally advanced carinoma of the uterine cervix

K. Moxley, L. Syzek, J. Walker, K. Moore, L. Landrum, D. McMeekin, R. Mannel

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

253

Lifestyle modification in cervical cancer survivors: An ongoing need

M. Schlumbrecht, C. Sun, S. Westin, F. Zandstra, C. Tung, K. Denton, H. Rhodes, E. Garcia, C. Levenback, D. Bodurka

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

254

Liquid-based cervical cytology in the detection of recurrence after treatment for cervical cancer

B. Rimel, A. Ferda, J. Erwin, S. Dewdney, L. Seamon, C. DeSimone, F. Gao, W. Huh, L. Massad

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 66 KB

english, 2011

255

Multicenter study on fertility-sparing laparoscopic radical trachelectomy

J. Nam, W. Joo, S. Chang, H. Yoo, J. Park, M. Jeong, D. Kim, J. Kim, Y. Kim, Y. Kim

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

256

Oncologic outcomes of radical trachelectomy at a single institution

C. Kim, N. Abu-Rustum, D. Chi, G. Gardner, M. Leitao, R. Barakat, Y. Sonoda

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

257

Oncologic outcomes of “cut through” radical trachelectomy for early-stage cervical cancer

Y. Sonoda, D. Chi, G. Gardner, M. Leitao, J. Carter, R. Barakat, N. Abu-Rustum

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 64 KB

english, 2011

258

Outcomes of surgery for stage IB cervical cancer: Variations between squamous and adenocarcinoma histology

E. Tanner, A. Iasonos, A. Kostolias, W. Tew, Q. Zhou, K. Park, K. Alektiar, R. Barakat, N. Abu-Rustum

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

259

Overall survival after pelvic exenteration for recurrent or persistent cervical cancer

S. Westin, V. Rallapalli, D. Urbauer, M. Frumovitz, L. Ramondetta, D. Bodurka, P. Ramirez, P. Soliman

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 65 KB

english, 2011

260

Oxygenation in cervical cancer and normal uterine cervix assessed using BOLD MRI: Initial experiences

J. Lea, R. Hallac, Y. Ding, Q. Yuan, R. McColl, D. Sims, P. Weatherall, R. Mason

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

261

Preoperative neutrophil/lymphocyte ratio as a prognostic factor in patients with early cervical cancer treated with radical hysterectomy

Y. Lee, C. Choi, H. Park, T. Song, M. Kim, T. Kim, J. Lee, J. Lee, D. Bae, B. Kim

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

262

Primary human papillomavirus screening with secondary VIA followed by cryotherapy

D. Starks, L. Nieves-Arriba, C. Enerson, S. Belinson, J. Brainard, A. Chiesa-Vottero, J. Belinson

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 66 KB

english, 2011

263

Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer

H. Chung, J. Eo, K. Han, S. Kang, K. Kang, J. Kim, N. Park, Y. Song

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

264

Prospective evaluation of PET/CT for lymph node status in FIGO stage IB–IIA cervical cancer

K. Lee, S. Lim, S. Cheon, S. Park, C. Park

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

265

Regionalization of gynecologic cancer care for African-Americans with cervical cancer: Does it benefit this subset of patients?

D. English, K. Brookfield, E. Schroeder, M. Cheung, S. Schuman, L. Koniaris

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 66 KB

english, 2011

266

Risk factors for fistula formation in patients with cervical cancer treated with radiation therapy include postradiation biopsy

J. Feddock, C. DeSimone, M. Kudrimoti, L. Baldwin, H. Weiss, M. Randall

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

267

The effectiveness of neodjuvant chemotherapy in cervical cancer stage IIB

B. Askandar, C. Santoso

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

268

Type-specific Tem-PCR versus Hybrid-Capture II for the detection of human papillomavirus

E. Campian, B. Jarnagin, S. Mahadasyam, J. Tatalovich

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

269

MECCS II: Primary screening for cervical cancer with an mRNA human papillomavirus assay

L. Nieves-Arriba, S. Belinson, C. Booth, J. Brainard, A. Chiesa-Vottero, C. Enerson, A. Perez, Z. Sun, J. Belinson

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 89 KB

english, 2011

270

Phase II study of adjuvant chemotherapy following concurrent chemoradiation using paclitaxel and carboplatin in cervical cancer: A preliminary report

D. Suh, H. Kim, M. Kim, H. Chung, H Kim, J. Kim, S. Kang, T. Lee, H. Lee

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 94 KB

english, 2011

271

Phase II study of belotecan (CKD-602) as a single agent in patients with recurrent or progressive carcinoma of the uterine cervix

J. Hwang, M. Lim, S. Seo, S. Park, S. Kang

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 105 KB

english, 2011

272

A cost minimization analysis of first-line treatment strategies for low-risk gestational trophoblastic neoplasia

N. Shah, L. Barroilhet, R. Berkowitz, C. Feltmate, M. Muto, D. Goldstein, N. Horowitz

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 105 KB

english, 2011

273

Chemotherapy-based treatment in uterine carcinosarcoma

S. Rose, J. Spencer

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 171 KB

english, 2011

274

Comparison of the new and old FIGO staging systems for vulvar carcinoma: A study of 4842 patients

A. Sultan, T. Kiet, R. Brooks, S. Ueda, L. Chen, D. Kapp, J. Chan

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 99 KB

english, 2011

275

Disparities in treatment and survival between African-American and white women with vaginal cancer

H. Mahdi, S. Kumar, A. Munkarah, R. Hanna, D. Lockhart, H. Tamimi, R. Swensen, M. Doherty

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 102 KB

english, 2011

276

Expression patterns of p53 and p21 cell cycle regulators and clinical outcome in women with pure gynecologic sarcomas

R. Voss, A. Suarez, R. Salani, D. Cohn, E. Eisenhauer

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

277

FIGO staging for carcinosarcoma: Can the new staging system predict overall survival?

T. Pradhan, E. Stevens, M. Ablavksy, G. Salame, Y. Lee, K. Economos, O. Abulafia

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

278

Human papillomavirus genotype in patients who developed vaginal intraepithelial neoplasia after treatment for cervical neoplasms

C. Lai, A. Chao, T. Chen, H. Chou, C. Huang, H. Huang, M. Jao

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 63 KB

english, 2011

279

Number of metastatic lymph nodes and locoregional control in vulvar cancer

S. Mahner, M. Choschzik, C. Eulenburg, M. Hager, F. Gieseking, J. Schwarz, F. Jaenicke, L. Woelber

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

280

Positive vulvar sentinel lymph node biopsy: A single-institution retrospective review

M. Tenney, E. Bishop, E. Nugent, L. Landrum, K. Moore, R. Mannel, J. Walker, M. Gold, D. McMeekin

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

281

Risk of second malignancies following extramammary Paget's disease

A. Karam, O. Dorigo

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 166 KB

english, 2011

282

Survival following ovarian versus uterine carcinosarcoma

L. Seamon, I. Podzielinski, B. Huang, C. DeSimone, B. Shelton, M. Randall, R. Ware, J. van Nagell, M. Cibull, F. Ueland

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 156 KB

english, 2011

283

The unique natural history of mucinous tumors of the ovary

M. Schiavone, T. Herzog, S. Lewin, I. Deutsch, X. Sun, W. Burke, J. Wright

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

284

Charlson's index: A validation study to predict surgical adverse events in gynecologic oncology

S. Kondalsamy-Chennakesavan, S. Johnson, J. Nicklin, R. Land, A. Garrett, A. Obermair

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

285

Clinical performance of a self-sustaining cervical cancer screening clinic in Nairobi, Kenya: The PAPS Team experience

Y. Lin, K. Matsuo, E. Yoo, M. Titus, G. Webley, G. Spears, L. Muderspach, N. Mugo, E. Thomas

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 65 KB

english, 2011

286

Cost-effectiveness of extended postoperative venous thromboembolism prophylaxis in gynecologic pncology patients

S. Uppal, V. Dandolu, E. Hernandez

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

287

High incidence of anal disease diagnosed from screening HIV-infected women with anal cytology and triage to high-resolution anoscopy

J. Hou, D. Smotkin, S. Isani, H. Smith, O. Ben-David, G. Goldberg, M. Einstein

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

288

Racial disparities in ovarian cancer surgical care: A population-based analysis

O. Ibeanu, M. Zahurak, R. Bristow

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 64 KB

english, 2011

289

Rapid high-risk human papillomavirus test shows excellent agreement with standard Hybrid Capture 2 when used onsite in rural northern Tanzania

J. Young, B. Badman, G. Lazenby, A. Nyanga'nyi, M. Stoler, P. Taylor

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

290

Stage IC ovarian cancer: Tumor rupture versus ovarian surface involvement

N. Barrena Medel, S. Lewin, I. Deutsch, Y. Qiao, X. Sun, W. Burke, T. Herzog, J. Wright

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 64 KB

english, 2011

291

Television and Internet sources of information negatively associated with human papillomavirus vaccination among college-age women

J. Young, A. Brown, L. Carr, J. Korte, S. Modesitt

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

292

The clinical and financial implications of MRI of pelvic masses

E. Ratner, S. Cross, P. Schwartz, S. McCarthy

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

293

Weighing the risks: The ecological relationship between obesity and early-onset endometrial cancer

R. Salani, J. Fisher, J. McLaughlin, E. Paskett, D. Cohn

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 65 KB

english, 2011

294

Clinical and economic impact following the introduction of robotics for endometrial cancer staging

Z. Vaknin, S. Lau, R. Agnihotram, N. Drummond, D. Halliday, R. Gotlieb, J. How, E. Franco, W. Gotlieb

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

295

Comparing robotic hysterectomy with alternate operative strategies for endometrial cancer: A feasibility analysis of cost equivalence from the societal perspective

N. Shah, K. Wright, G. Jonsdottir, S. Jorgensen, J. Einarrson, M. Muto

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 134 KB

english, 2011

296

Comparison of robot-assisted and standard laparoscopic procedures in patients with endometrial cancer

M. Leitao, G. Gardner, G. Briscoe, K. Santos, E. Jewell, N. Abu-Rustum, C. Brown, D. Chi, Y. Sonoda, R. Barakat

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 116 KB

english, 2011

297

Criteria for the safety of less radical trachelectomy in early-stage cervical cancer: A multicenter study

M. Kim, H. Kim, Y. Jeon, Y. Kim, T. Kim, M. Lim, C. Choi, S. Chang, S. Park, B. Kim, J. Kim

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 174 KB

english, 2011

298

Endometrial cancer as a platform for training residents in robotic hysterectomy techniques

M. Finan, R. Rocconi

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 92 KB

english, 2011

299

Fertility-sparing surgery for treatment of early-stage cervical cancer: Open versus robotic radical trachelectomy

A. Nick, M. Frumovitz, K. Schmeler, P. Soliman, P. Ramirez

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 106 KB

english, 2011

300

Integration of and training for robot-assisted surgery in a gynecologic oncology fellowship program

M. Leitao, G. Gardner, G. Briscoe, K. Santos, E. Jewell, C. Brown, D. Chi, R. Barakat

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 46 KB

english, 2011

301

Outcomes of patients with gynecologic malignancies undergoing video-assisted thorascopic surgery and pleurodesis for malignant pleural effusion

J. Whitworth, A. Bryant, R. Cerfolio, K. Schneider, J. Fauci, J. Straughn

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 63 KB

english, 2011

302

Perioperative and pathologic outcomes following robot-assisted laparoscopic versus abdominal management of ovarian cancer

G. Feuer, M. Burrell, S. Salmieri, P. Hernandez

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

303

Postoperative analgesic and antiemetic requirements after minimally invasive surgery for early cervical cancer: Is the robot better?

P. Soliman, G. Langley, R. dos Reis, M. Frumovitz, K. Schmeler, A. Nick, P. Ramirez

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

304

Postoperative pain medication requirements in patients undergoing robotically assisted and standard laparoscopic procedures for newly diagnosed endometrial cancer

M. Leitao, G. Gardner, G. Briscoe, P. Dholakiya, K. Santos, E. Jewell, N. Abu-Rustum, Y. Sonoda, R. Barakat, V. Malhotra

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 141 KB

english, 2011

305

Predictive risk factors for prolonged hospitalizations after gynecologic laparoscopic surgery

B. Zand, A. Nick, H. Sangi-Haghpeykar, M. Frumovitz, P. Soliman, K. Schmeler, P. Ramirez

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 125 KB

english, 2011

306

Robot-assisted laparoscopic hysterectomy is superior for endometrial cancer in the morbidly obese

A. Maddock, R. Pierre, T. Ford, D. Kredentser, T. McElrath, T. Morrissey, P. Timmins

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 140 KB

english, 2011

307

Robot-assisted surgery for gynecologic cancer: A systematic review

D. Lu, G. Shi, Z. Liu, D. Liu, X. Zhou

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

308

Robotic radical hysterectomy: Extent of tumor resection and operative outcomes compared with laparoscopy and exploratory laparotomy

G. Gardner, M. Leitao, M. Carreras, E. Jewell, Y. Sonoda, D. Levine, N. Abu-Rustum, C. Brown, D. Chi, R. Barakat

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 65 KB

english, 2011

309

Surgery–adjuvant therapy interval in women with endometrial cancer staged with robot-assisted laparoscopy versus laparotomy

E. Simons, L. Huang, S. Messing, E. Toy

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

310

Surgical outcomes of robot-assisted surgical staging for morbidly obese (BMI > 40) patients with endometrial cancer: Technique for morbidly obese patients

P. Singhal, H. Haque Aziz, G. Tyler, D. Marchetti

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

311

Surgical volume and its effect on morbidity and mortality for endometrial cancer

S. Lewin, T. Herzog, I. Deutsch, X. Sun, W. Burke, J. Wright

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 62 KB

english, 2011

312

Two-port access staging laparoscopy for endometrial cancer: A case–control study

G. Yim, S. Kim, J. Paek, E. Nam, Y. Kim, S. Lee, M. Lee, J. Kim

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

313

Utilization of specialized postoperative services in a comprehensive surgical cytoreduction program

K. Long, E. Tanner, R. Brightwell, K. Shih, Y. Sonoda, M. Leitao, N. Abu-Rustum, R. Barakat, D. Chi

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

314

Author Index

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 111 KB

english, 2011

315

Subject Index

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 320 KB

english, 2011

316

Foreword

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 97 KB

english, 2011

317

Editorial Board

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 1.39 MB

english, 2011

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски